The integrated Z-value of FNDC3B expression in GBM was −2.50 (p < 0.01), indicating that high FNDC3B expression in GBM patients had worse overall survival prognosis (Figure 1c, Table S2). This evidence concerns the gene FNDC3B and glioblastoma.